Your session is about to expire
← Back to Search
Caring Contacts for Suicide Prevention (CARE Trial)
N/A
Waitlist Available
Led By Lonnie A Nelson, PhD
Research Sponsored by Washington State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be 18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 and 18 months
Awards & highlights
CARE Trial Summary
This trial will evaluate how well a low-cost, sustainable intervention called Caring Contacts works to prevent suicide among American Indians and Alaska Natives aged 18 and older.
Who is the study for?
This trial is for American Indian or Alaska Native adults who are at least 18 years old, can speak and read English, have had suicidal thoughts or an attempt within the past year, and are willing to receive messages by text, email, or mail. It's not for those unable to consent independently.Check my eligibility
What is being tested?
The study tests 'Caring Contacts', a suicide prevention approach that involves sending supportive messages to individuals at risk. The effectiveness of this low-cost intervention will be evaluated across four tribal communities.See study design
What are the potential side effects?
Since 'Caring Contacts' involves sending caring messages without medical treatment, there are no direct physical side effects expected from the intervention itself.
CARE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 years old or older.
CARE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 and 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 and 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Suicidal Ideation Questionnaire (SIQ)
Suicide Attempt and Self-Injury Count (SASI-Count)
Suicide-related hospitalizations
Secondary outcome measures
Interpersonal Needs Questionnaire (INQ) Thwarted Belongingness subscale
CARE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Usual Care + Caring Contacts messagesExperimental Treatment2 Interventions
Usual care services plus caring contacts messages
Group II: Usual CareActive Control1 Intervention
Usual care services provided in that community following identification of suicidal ideation or behavior.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Usual Care
1990
Completed Phase 4
~7700
Find a Location
Who is running the clinical trial?
Washington State UniversityLead Sponsor
101 Previous Clinical Trials
56,003 Total Patients Enrolled
University of WashingtonOTHER
1,738 Previous Clinical Trials
1,843,640 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
40 Patients Enrolled for Suicidal Thoughts
National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,688,438 Total Patients Enrolled
1 Trials studying Suicidal Thoughts
240 Patients Enrolled for Suicidal Thoughts
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I am okay with being contacted through text, email, or mail.I am willing and able to join the study voluntarily.I am unable to understand or sign the consent form by myself.
Research Study Groups:
This trial has the following groups:- Group 1: Usual Care + Caring Contacts messages
- Group 2: Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial still have open spots for participants?
"According to clinicaltrials.gov, the recruitment phase for this trial has ended as of October 13th 2022. Although this specific medical study is not currently enrolling participants, there are 215 other trials actively recruiting new patients at present."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger